NCT03771781View on ClinicalTrials.gov

Bioequivalence Study of Empagliflozin Tablet in Healthy Participants.

NACompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

April 16, 2018

Primary Completion Date

May 25, 2018

Study Completion Date

May 25, 2018

Conditions
Type 2 Diabetes
Interventions
DRUG

Empagliflozin Tablets

Observe the safty and PK after subjects receiving a single dose of Empagliflozin Tablets.

DRUG

Empagliflozin Tab 25 MG

Observe the safty and PK after subjects receiving a single dose of Empagliflozin Tablets( Jardiance®）.

Trial Locations (1)

410000

The Third Hospital of Changsha, Changsha

Sponsors
All Listed Sponsors
lead

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

INDUSTRY